Wainer Andrea F
SEC CIK 1778070 · EDGAR
BoughtSold
Most active insiders at ADI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROCHE VINCENT | COB, CEO, Dir | — | $63.58M |
| 2 | STATA RAY | Dir | — | $15.27M |
| 3 | Cotter Martin | SVP, Vertical Business Units | — | $11.49M |
| 4 | Sondel Michael | CAO (principal acct. Off.) | — | $6.07M |
| 5 | Puccio Richard C Jr | EVP, CFO | — | $2.12M |
| 6 | Jain Vivek | EVP, Gbl Ops | — | $1.57M |
| 7 | Golz Karen | Dir | — | $1.18M |
| 8 | Nakamura Katsufumi | SVP, Chief Customer Off | — | $295.3K |
| 9 | Frank Edward H. | Dir | — | $242.7K |
| 10 | Andonian Andre' | Dir | — | — |
| 11 | Wainer Andrea F | Dir | — | — |
Transactions 40
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | 2026-03-11 | ADI | Analog Devices | Wainer Andrea F | Dir | A - Grant | $0.00 | +747 | 2,325 | +47% | $0 | |
| D | 2025-10-27 | 2025-10-23 | NEOG | NEOGEN CORP | Wainer Andrea F | Dir | A - Grant | $6.07 | +19.8K | 19.8K | New | +$120.0K |
| D | 2025-06-04 | 2025-06-02 | NEOG | NEOGEN CORP | Wainer Andrea F | Dir | A - Grant | $5.69 | +6,090 | 6,090 | New | +$34.7K |
| 2025-03-14 | 2025-03-12 | ADI | Analog Devices | Wainer Andrea F | Dir | A - Grant | $0.00 | +1,160 | 1,596 | +266% | $0 | |
| 2025-03-04 | 2025-02-28 | ABT | Abbott Laboratories | Wainer Andrea F | RETIRED EVP | F - Tax | $135.87 | -7,313 | 75.3K | -9% | -$993.6K | |
| 2025-03-04 | 2025-03-03 | ABT | Abbott Laboratories | Wainer Andrea F | RETIRED EVP | S - Sale | $138.17 | -949 | 74.4K | -1% | -$131.1K | |
| D | 2025-02-27 | 2025-02-25 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | A - Grant | $0.00 | +12.3K | 82.6K | +17% | $0 |
| 2024-03-04 | 2024-02-29 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | F - Tax | $120.05 | -8,339 | 70.4K | -11% | -$1.00M | |
| D | 2024-02-27 | 2024-02-23 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $120.00 | -12.5K | 78.7K | -14% | -$1.50M |
| D | 2024-02-27 | 2024-02-23 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $59.94 | +12.5K | 91.2K | +16% | +$749.2K |
| D | 2024-02-23 | 2024-02-21 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | A - Grant | $0.00 | +13.7K | 78.7K | +21% | $0 |
| DM | 2024-01-31 | 2024-01-29 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $50.80 | +42.5K | 82.5K | +106% | +$2.16M |
| DM | 2024-01-31 | 2024-01-29 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $112.50 | -42.5K | 65.0K | -40% | -$4.78M |
| D | 2023-12-18 | 2023-12-14 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $44.40 | +15.0K | 80.0K | +23% | +$666.0K |
| D | 2023-12-18 | 2023-12-14 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $108.00 | -15.0K | 65.0K | -19% | -$1.62M |
| DM | 2023-08-10 | 2023-08-08 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $105.03 | -10.4K | 65.0K | -14% | -$1.09M |
| D | 2023-08-10 | 2023-08-08 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $38.40 | +5,000 | 75.4K | +7% | +$192.0K |
| D | 2023-05-03 | 2023-05-02 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $47.00 | +8,226 | 78.7K | +12% | +$386.6K |
| D | 2023-05-03 | 2023-05-02 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $110.56 | -8,226 | 70.4K | -10% | -$909.5K |
| 2023-03-02 | 2023-03-01 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale | $100.70 | -679 | 70.4K | -1.0% | -$68.4K | |
| 2023-03-02 | 2023-02-28 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | F - Tax | $99.77 | -7,531 | 71.1K | -10% | -$751.4K | |
| D | 2023-02-22 | 2023-02-17 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | A - Grant | $0.00 | +18.2K | 78.6K | +30% | $0 |
| 2022-06-07 | 2022-06-03 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | F - Tax | $117.51 | -1,768 | 60.4K | -3% | -$207.8K | |
| 2022-03-02 | 2022-02-28 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | F - Tax | $122.41 | -6,126 | 62.6K | -9% | -$749.9K | |
| 2022-03-02 | 2022-03-01 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale | $118.13 | -456 | 62.2K | -0.7% | -$53.9K | |
| D | 2022-02-23 | 2022-02-18 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | A - Grant | $0.00 | +19.0K | 68.8K | +38% | $0 |
| DM | 2021-12-28 | 2021-12-23+ | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $41.62 | +16.0K | 62.8K | +34% | +$666.0K |
| DM | 2021-12-28 | 2021-12-23+ | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $140.47 | -16.0K | 49.8K | -24% | -$2.25M |
| D | 2021-12-21 | 2021-12-17 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $47.00 | +7,500 | 57.3K | +15% | +$352.5K |
| D | 2021-12-21 | 2021-12-17 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $137.54 | -7,500 | 49.8K | -13% | -$1.03M |
| DM | 2021-12-15 | 2021-12-13 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $42.55 | +14.5K | 56.8K | +34% | +$617.0K |
| D | 2021-12-15 | 2021-12-13 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $135.00 | -14.5K | 49.8K | -23% | -$1.96M |
| D | 2021-12-08 | 2021-12-06 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $132.50 | -4,500 | 49.8K | -8% | -$596.2K |
| D | 2021-12-08 | 2021-12-06 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $47.00 | +4,500 | 54.3K | +9% | +$211.5K |
| DM | 2021-11-17 | 2021-11-15 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $41.84 | +12.5K | 62.3K | +25% | +$523.0K |
| D | 2021-11-17 | 2021-11-15 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $130.01 | -12.5K | 49.8K | -20% | -$1.63M |
| DM | 2021-09-03 | 2021-09-02 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $42.47 | +9,500 | 59.3K | +19% | +$403.5K |
| D | 2021-09-03 | 2021-09-02 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $127.50 | -9,500 | 49.8K | -16% | -$1.21M |
| DM | 2021-08-19 | 2021-08-17 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | M - OptEx | $41.07 | +14.5K | 64.3K | +29% | +$595.5K |
| D | 2021-08-19 | 2021-08-17 | ABT | Abbott Laboratories | Wainer Andrea F | EVP | S - Sale+OE | $125.00 | -14.5K | 49.8K | -23% | -$1.81M |
Purchase Sale Sale after option exercise All abbreviations